Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
didox
Description:
Didox is an antineoplastic chemical compound that inhibits ribonucleotide reductase and has been studied in cancer and retroviral disease research.
Related topics:
Estrogen and related hormone effects (12%),
HIV/AIDS drug development and treatment (10%)
Wikidata ID:
wiki/Q27282568
OpenAlex ID:
keywords/didox
Didox and resveratrol sensitize colorectal cancer cells to doxorubicin via activating apoptosis and ameliorating P-glycoprotein activity
2016
·
Sahar A. Khaleel
, Ahmed M. Al-Abd
, et al.
·
Scientific Reports
·
95
PDF
Down-regulation of deoxycytidine kinase in human leukemic cell lines resistant to cladribine and clofarabine and increased ribonucleotide reductase activity contributes to fludarabine resistance
2002
·
Emma Månsson
, Emma Flordal
, et al.
·
Biochemical Pharmacology
·
89
Targeting Ribonucleotide Reductase M2 and NF-κB Activation with Didox to Circumvent Tamoxifen Resistance in Breast Cancer
2015
·
Khyati N. Shah
, Elizabeth A. Wilson
, et al.
·
Molecular Cancer Therapeutics
·
69
Compromised axon initial segment integrity in EAE is preceded by microglial reactivity and contact
2016
·
Kareem C. Clark
, Anna Josephson
, et al.
·
Glia
·
65
Clinical pharmacology and clinical trials of ribonucleotide reductase inhibitors: is it a viable cancer therapy?
2017
·
Mukundan Baskar Mannargudi
, Subrata Deb
·
Journal of Cancer Research and Clinical Oncology
·
57
Potential tumor‑suppressive role of microRNA‑99a‑3p in sunitinib‑resistant renal cell carcinoma cells through the regulation of RRM2
2019
·
Yoichi Osako
, Hirofumi Yoshino
, et al.
·
International Journal of Oncology
·
56
PDF
A phase 1 and pharmacokinetic study of didox: A ribonucleotide reductase inhibitor
1988
·
D Veale
, J Carmichael
, et al.
·
British Journal of Cancer
·
48
PDF
RRM2 Alleviates Doxorubicin-Induced Cardiotoxicity through the AKT/mTOR Signaling Pathway
2022
·
Yuheng Jiao
, Yanyan Li
, et al.
·
Biomolecules
·
43
PDF
Activation of caspases and induction of apoptosis by novel ribonucleotide reductase inhibitors amidox and didox
2001
·
Michael Grusch
, Monika Fritzer-Szekeres
, et al.
·
Experimental Hematology
·
42
Acute neuroinflammation induces AIS structural plasticity in a NOX2-dependent manner
2017
·
S. D. Benusa
, N. M. George
, et al.
·
Journal of Neuroinflammation
·
38
PDF
Ribonucleotide reductase inhibitors enhance cidofovir‐induced apoptosis in EBV‐positive nasopharyngeal carcinoma xenografts
2005
·
Naohiro Wakisaka
, Tomokazu Yoshizaki
, et al.
·
International Journal of Cancer
·
37
PDF
Kinetic studies on the reduction of the tyrosyl radical of the R2 subunit of E. coli ribonucleotide reductase
1995
·
Jannie C. Swarts
, Manuel A.S. Aquino
, et al.
·
Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology
·
37
The chemomodulatory effects of resveratrol and didox on herceptin cytotoxicity in breast cancer cell lines
2015
·
Ghada A. Abdel-Latif
, Ahmed M. Al-Abd
, et al.
·
Scientific Reports
·
35
PDF
3,4-Dihydroxy-benzohydroxamic acid (Didox) suppresses pro-inflammatory profiles and oxidative stress in TLR4-activated RAW264.7 murine macrophages
2015
·
Thabe M. Matsebatlela
, Amy L. Anderson
, et al.
·
Chemico-Biological Interactions
·
35
In Vivo and In Vitro Comparison of the Short‐Term Hematopoietic Toxicity Between Hydroxyurea and Trimidox or Didox, Novel Ribonucleotide Reductase Inhibitors with Potential Anti‐HIV‐1 Activity
1999
·
Christopher N. Mayhew
, Jonathan D. Phillips
, et al.
·
Stem Cells
·
35
Phase II trial of didox in advanced breast cancer
1991
·
RD Rubens
, SB Kaye
, et al.
·
British Journal of Cancer
·
33
PDF
A phase I and pharmacokinetic study of didox administered by 36 hour infusion
1990
·
J Carmichael
, BMJ Cantwell
, et al.
·
British Journal of Cancer
·
31
PDF
Combined effects of temozolomide and the ribonucleotide reductase inhibitors didox and trimidox in malignant brain tumor cells
2003
·
M. Figul
, A. S�ling
, et al.
·
Cancer Chemotherapy and Pharmacology
·
30
Interaction of gallium nitrate with other inhibitors of ribonucleotide reductase: effects on the proliferation of human leukemic cells
1998
·
Michael S Myette
, Howard L Elford
, et al.
·
Cancer Letters
·
30
Ribonucleotide reductase inhibitors hydroxyurea, didox, and trimidox inhibit human cytomegalovirus replication in vitro and synergize with ganciclovir
2013
·
Sukhada Bhave
, Howard Elford
, et al.
·
Antiviral Research
·
28
Enhancement of hemoglobin and F-cell production by targeting growth inhibition and differentiation of K562 cells with ribonucleotide reductase inhibitors (didox and trimidox) in combination with streptozotocin
2000
·
W.E. Iyamu
, S.E. Adunyah
, et al.
·
American Journal of Hematology
·
27
Didox potentiates the cytotoxic profile of doxorubicin and protects from its cardiotoxicity
2013
·
Ahmed M. Al-Abd
, Fahad A. Al-Abbasi
, et al.
·
European Journal of Pharmacology
·
26
Didox, a ribonucleotide reductase inhibitor, induces apoptosis and inhibits DNA repair in multiple myeloma cells
2006
·
N. Raje
, S. Kumar
, et al.
·
British Journal of Haematology
·
25
PDF
Suppression of retrovirus-induced immunodeficiency disease (murine AIDS) by trimidox and didox
2002
·
Christopher N Mayhew
, Leseilane J Mampuru
, et al.
·
Antiviral Research
·
24
Robust Vascular Protective Effect of Hydroxamic Acid Derivatives in a Sickle Mouse Model of Inflammation
2006
·
DHANANJAY K. KAUL
, RAHN KOLLANDER
, et al.
·
Microcirculation
·
20
Show more works
View as search
Works count:
134
Citation count:
1,498
Year
Topic
Type